Additional Investigations To Be Carried Out by The FDA Over Tylenol Products

May 18th, 2010 - 11:28 pm ICT by Pen Men At Work  

May 18, 2010 (Pen Men at Work): The difficulties of Johnson & Johnson over Tylenol appear to have intensified. William Weldon, J&J Chief Executive, will be stating under oath on May 27 during the inquiry with the House Committee on Oversight.

The company had, in recent times, recalled 40 popular medications utilized to take care of children’s twinge. There are additional signals that this recall could become worse. The American Food and Drug Administration (FDA) had examined and mentioned about negligence in the creation of the products and about them being infected. The Food and Drug Administration enunciated on Monday that it is administering supplementary inquiries on the recall of certain drugs by Johnson & Johnson.

The Pennsylvania plant that was scrutinized was shut down after FDA authorities discovered thick grime, dirt and polluted ingredients. It is to be mentioned that this is the same plant that constructs children’s Tylenol as well as dozens of other products.

It was articulated that the aforementioned plant did not keep up satisfactory laboratory amenities for the examination and endorsements of components of drug products. It also said that the shortage of appropriate controls in the manufacturing procedure led to some batches of infants’ Tylenol possessing too much of some constituents.

An admired and reputable company like Johnson & Johnson discharged four recalls in the past year for over the counter medicines. The conclusion of the May 27 inquiry is being keenly awaited.

Related Stories

Tags: , , , , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe